Shandong BellaGen Biotechnology Co, a high-tech company based in Jinan, capital of East China's Shandong province, is a national leader in developing cutting-edge gene-editing technology.

The company specializes in the development of gene editing technology and its industrial applications in fields such as agricultural biotechnology, gene detection, and medical industries.

It is the first Chinese company to independently develop CRISPR Cas SF01 and CRISPR Cas SF02 core gene-editing technologies.

Now, the company's gene-editing technologies have been exported abroad, making it the first company in China to provide multinational corporations with patent licenses and technical solutions in this field.

BellaGen Biotechnology has built a world-class research and development platform for gene editing, established a platform for biological breeding and formed an innovation system integrating gene editing and cutting-edging technologies.

According to Li Guofu, deputy general manager of BellaGen, the company has cultivated over 20 new high-yield crop varieties, including high-yield rice and high-oleic soybeans, which have obtained the necessary certificates for industrial production.

The seedlings of high-oleic soybeans cultivated by Shandong BellaGen Biotechnology Co. [Photo/provided to chinadaily.com.cn]